Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroid vs PRP vs incubated PRP for partial-thickness rotator cuff tears
IRCT20260106068578N1Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- May 2026
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of platelet-rich plasma in rotator cuff tear and Supraspinatus tear (SST) (3 arms), sponsored by Kerman University of Medical Sciences. Primary endpoints: Identification of effective non-surgical treatment modalities for partial-thickness rotator cuff tears, Pain relief and 1 more. Started May 2026; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
rotator cuff tearSupraspinatus tear (SST)
Beyond the preview
Go deeper on IRCT20260106068578N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260106068578N1.